Showing results (161-170 of 229) with videos related to

Sort By:
Pageof 23
Innovation (Cambridge (Mass.))|July 23, 2025
Adjuvant HAIC combined with anlotinib and TQB2450 for resected high-risk hepatocellular carcinomaNing Zhang, Yongfa Zhang, Bingran Yu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 6, 2026
A platelet-monocyte pyroptotic axis mediates uremic cardiomyopathy: critical role of PF4 and hematopoietic caspase-1Yang Yang, Minyu Zhang, Meihan Chen, et al.
ACS Nano|August 15, 2022
Chiral FA Conjugated CdTe/CdS Quantum Dots for Selective Cancer AblationGuangmin Li, Xihao Zhang, Xuening Fei, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 3, 2010
[Treatment of recurrent malignant gliomas by surgery combined with recombinant adenovirus-p53 injection]Jian-xin Zhu, Zhong-min Li, Feng-yang Geng, et al.
Clinical Kidney Journal|June 5, 2024
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathyWen Xia, Jiayi Deng, Lulu Zhuang, et al.
Surgical Endoscopy|January 1, 2017
Five hundred consecutive laparoscopic common bile duct explorations: 5-year experience at a single institutionJie Hua, Hongbo Meng, Le Yao, et al.
Oncotarget|December 30, 2017
Apatinib is effective for treatment of advanced hepatocellular carcinomaYinlong Kong, Lin Sun, Zhenyu Hou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 27, 2023
Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT/mTOR pathwayChengmeng Wang, Lu Zhang, Manqing Cao, et al.
Surgical Endoscopy|February 23, 2021
Safety and efficacy of laparoscopic common bile duct exploration for the patients with difficult biliary stones: 8 years of experiences at a single institution and literature reviewZhilong Ma, Jia Zhou, Le Yao, et al.
Translational Cancer Research|February 4, 2022
Resection of "down-staged" advanced hepatocellular carcinoma after treatment with the VEGFR2 inhibitor apatinib: five cases reportZhenyu Hou, Keyun Zhu, Xuejiao Yang, et al.
Pageof 23